Leigh Burgess, CEO and founder of Bold Industries Group, reveals how applying design thinking can transform clinical research operations. Learn how radical prioritization and the innovative D90 framework can help organizations cut through complexity, enhance teamwork, and accelerate trial results — delivering more efficient outcomes for patients and stakeholders alike.